Hospice & palliative care

Where the Financial Pressure Shows Up in Care

Save

The hospice benefit's payment design creates a plain incentive: revenue holds steady whether a hospice sends a nurse out twice a week or twice a month. That doesn't mean every hospice cuts corners, but it does mean the pressure is structural, not anecdotal, and researchers have been able to measure exactly where it tends to surface — in caregiver-reported experience, in staffing intensity, and in who gets discharged alive and why.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Why Would a Hospice Have Any Incentive to Cut Back?

The hospice benefit pays a per-diem rate: a set amount for each day a patient is enrolled, not a fee tied to the number of visits, minutes of nursing time, or level of clinical effort that day 1. That structure exists to keep hospice sustainable and predictable to administer, and it works well for most patients most of the time. But it also means a hospice's costs go down, and its margin goes up, on any day it delivers less care than the per-diem rate assumes — a nurse visit skipped, a social work check-in postponed, an on-call question answered by phone instead of a home visit. Nothing about the payment model requires a hospice to behave this way. It simply removes the financial penalty for choosing not to.

What Does the Research Actually Show?

A national analysis of CAHPS Hospice survey results — the standardized instrument that measures family caregivers' experience with a hospice's actual care 2 — found that for-profit hospices scored worse than not-for-profit hospices across every domain measured, including communication, symptom management, and caregivers' willingness to recommend the hospice to others 3. That's not one weak metric; it's a consistent pattern across the entire survey. A separate body of research on live discharge found that hospices with unusually high rates of discharging patients alive, in ways not clearly explained by clinical improvement, are disproportionately for-profit 4. Ownership alone doesn't determine any one hospice's quality, but at a population level, the pattern is measurable and repeated across independent studies. The gap shows up specifically in the domains families feel most directly: how well a hospice controlled pain and other symptoms, how clearly the team communicated about what to expect, and how promptly someone responded when a family called for help — not just in a single overall star rating.

What Happens When a Discharge Doesn't Add Up Clinically?

A cohort study following Medicare beneficiaries discharged alive from hospice found they were substantially more likely to be hospitalized, readmitted to hospice, or to die in a hospital shortly afterward — and that risk climbed further among patients who'd had unusually short hospice stays and those cared for by for-profit hospices 5. That's a costly pattern for a family in the moment: a patient who was supposed to be resting at home with support instead ends up back in an ambulance. It's also a pattern regulators track deliberately, not incidentally, because a discharge that routes someone back through the emergency department is close to the opposite of what hospice is supposed to do.

Where Does the Pressure Actually Show Up Day to Day?

The financial incentive rarely announces itself; it shows up as a series of small, individually explainable choices. A nurse visit that gets scheduled for every other week instead of weekly as a patient declines. An after-hours call that's handled entirely by phone from a triage line reading a script, rather than a nurse who knows the patient coming out to the house. A social work or chaplain visit that keeps getting rescheduled rather than prioritized. None of these choices is necessarily wrong in any single instance — clinical judgment genuinely varies, and not every decline calls for more frequent visits. The pattern worth watching for is whether they cluster in one direction, consistently toward less care rather than more, across an entire course of hospice enrollment.

How Does Medicare Try to Contain the Incentive?

Medicare's oversight body for hospice payment policy monitors margins, utilization patterns, and long-stay growth specifically because per-diem financing rewards enrolling patients who need relatively little day-to-day care and discourages care-intensive cases 6. That same reporting has tracked years of growth in for-profit hospice enrollment alongside these utilization patterns, treating it as an ongoing payment and quality concern rather than a settled issue. Medicare also caps how much a hospice can be paid in total per patient over a benefit year, which is meant to discourage enrolling patients who will stay on hospice for a very long time relative to the acuity of their needs 6. None of this oversight replaces a family's own judgment about a specific hospice, but it's a sign the incentive is well understood and actively monitored at the policy level, not a fringe theory.

Does This Mean Every For-Profit Hospice Is Cutting Corners?

No. Ownership status is a population-level pattern, not a verdict on any individual hospice — plenty of for-profit hospices deliver excellent, well-staffed care, and plenty of nonprofits fall short of their mission. Even so, the three kinds of hospice organizations — nonprofit, hospital-based, and for-profit — sit under meaningfully different financial pressures before private equity involvement is even considered, and hospice ownership is the detail worth asking about directly, including whether a specific hospice is a private equity hospice acquisition. Reviewing hospice conflicts of interest as a category is one way to think about this pressure systematically, and comparing hospice chains against local, independently run hospices on their own published numbers — CAHPS scores, live discharge pattern, and how directly each answers questions about staffing — matters more than assuming either structure is automatically safer.

What Can a Family Actually Check?

Care Compare publishes each hospice's CAHPS Hospice results, which is the single most direct way to see whether a specific hospice's own family-reported experience matches the pattern described above or breaks from it. Ownership type is disclosed on the same listing. Beyond the published data, a family can ask a hospice directly how many visits per week a patient at a given level of care typically receives, whether that number is written into the plan of care, and what triggers a change in visit frequency as a patient declines. A hospice confident in its staffing model answers these questions specifically; one relying on the payment structure's slack tends to answer in generalities.

Common questions

No. Medicare's hospice benefit pays a flat daily rate regardless of how many visits happen that day, so visit frequency doesn't change a hospice's daily revenue for routine home care. That structure is what creates the incentive researchers have studied: less delivered care costs a hospice less without reducing what it's paid.

Not always, but the research finds a consistent population-level gap. For-profit hospices score lower on family-reported experience across every CAHPS domain on average, and unexplained live-discharge patterns are more common among them. Individual hospices vary, so a specific hospice's own published data matters more than its ownership label alone.

Ask directly how many visits per week a patient at a given level of care typically gets and what's written into the plan of care, then compare that against what actually happens after enrollment. A hospice's CAHPS Hospice score on Care Compare also reflects whether other families experienced this same gap.

Per-diem payment keeps hospice billing predictable and administratively simple compared with paying for every individual service, and it works well for the majority of patients. Medicare's payment oversight body tracks the trade-off's effects, including margins and discharge patterns, as an ongoing area of policy monitoring rather than an unaddressed problem.

Not automatically — some patients genuinely stabilize and no longer need hospice. But an unusually high rate of live discharge without a clear clinical explanation is the specific pattern researchers have tied more often to for-profit hospices, and it's a legitimate reason to ask a hospice directly what's driving its numbers.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When Financial Pressure Is Affecting Actual Care

  • —visits that are consistently shorter or less frequent than what's written in the plan of care
  • —pain or symptoms that stay uncontrolled despite repeated calls to the hospice
  • —a discharge recommendation with no specific clinical explanation, arriving shortly after a short stay
  • —a hospice that won't answer direct questions about typical visit frequency or staffing

If symptoms become severe or unmanaged, call the hospice's 24-hour clinical line first; call 911 if the hospice can't be reached and the situation is immediately life-threatening.

This article explains a general financial incentive in hospice payment and published research patterns; it is not an assessment of any specific hospice. A hospice's own CAHPS Hospice results and live discharge data on Care Compare are the sources to check for a specific agency.

References

  1. 1.Centers for Medicare & Medicaid Services (2024). Hospice Benefit Toolkit. Centers for Medicare & Medicaid Services (CMS). link ✓The general structure of the Medicare hospice benefit, including that it is administered as a benefit rather than paid per individual service.
  2. 2.Agency for Healthcare Research and Quality (2024). CAHPS Hospice Survey. Agency for Healthcare Research and Quality (AHRQ). link ✓That CAHPS Hospice is the standardized, validated instrument for measuring family caregivers' experience of a hospice's actual care.
  3. 3.Anhang Price R, Parast L, Elliott MN, et al. (2023). Association of Hospice Profit Status With Family Caregivers' Reported Care Experiences. JAMA Internal Medicine. doi:10.1001/jamainternmed.2022.7076 ✓That for-profit hospices score worse than not-for-profit hospices across every CAHPS Hospice domain measured, including willingness to recommend.
  4. 4.Teno JM, Plotzke M, Christian T, Gozalo P (2015). Characteristics of Hospice Programs With Problematic Live Discharges. Journal of Pain and Symptom Management. PMID 26004403That hospices with unusually high, medically unclear live-discharge rates are disproportionately for-profit.
  5. 5.Peer-reviewed cohort study (see article) (2024). Hospice Readmission, Hospitalization, and Hospital Death Among Patients Discharged Alive from Hospice. JAMA Network Open (PMC11099680). PMID 38753329 ✓That patients discharged alive from hospice face higher rates of hospitalization, readmission, and hospital death, with elevated risk among short-stay and for-profit-hospice patients.
  6. 6.Medicare Payment Advisory Commission (2025). Report to the Congress: Medicare Payment Policy - Chapter 9: Hospice Services (March 2025). Medicare Payment Advisory Commission (MedPAC). link ✓That Medicare's payment oversight body tracks hospice margins, utilization, and for-profit growth as an ongoing payment-policy concern.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library